| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |